Subscribe to our newsletter

Atopic Dermatitis Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
+
STUDY VISITS
+
PATIENTS
+
DERMATOLOGISTS

Outcome measures in the CorEvitas AD Registry.

In addition to demographics, clinical features, medication history and changes, and comorbidities, key outcome measures collected include:

Clinician Reported Outcomes

Patient Reported Outcomes

Active safety assessments using structured data fields are collected with supporting documents to meet regulatory requirements and post marketing commitments of manufacturers.

Registry Scientific Advisors

Jonathan Silverberg, MD, PhD, MPH, FAAD

Jonathan Silverberg, MD, PhD, MPH, FAAD

Professor of Dermatology, George Washington University School of Medicine and Health Sciences in Washington, DC

Eric Simpson, MD, MCR

Eric Simpson, MD, MCR

Professor of Dermatology, School of Medicine, Oregon Health & Science University, Portland, Oregon

Saturday September 7, 2019

Our Publications